Short Description
Etoposide 100mg/5ml Injection is a chemotherapy medicine containing etoposide, used to treat certain types of cancer. It belongs to a class of medicines called topoisomerase II inhibitors, which interfere with cancer cell growth and multiplication. It is generally used as part of a combination chemotherapy regimen, depending on the type of cancer being treated.
What Is Etoposide 100mg/5ml Injection?
Etoposide 100mg/5ml Injection contains 100mg of etoposide in 5ml of solution, equivalent to a concentration of 20mg/ml. It is an antineoplastic medicine administered intravenously after appropriate dilution.
Etoposide belongs to the topoisomerase II inhibitor class of chemotherapy medicines. It is used in the treatment of certain cancers by interfering with the processes cancer cells need to grow and multiply.
Uses
Etoposide 100mg/5ml Injection may be prescribed to:
Small cell lung cancer: In combination with other chemotherapy medicines as part of cancer treatment.
Testicular cancer: For certain refractory testicular tumours, particularly when previous treatment has not been successful, in combination with other chemotherapy medicines.
Other uses may be considered by specialists depending on the cancer type, treatment protocol and applicable product approval.
The appropriate treatment regimen and dose must be determined by an oncologist based on the patient's condition, body surface area, previous treatment and response to therapy.
How Does Etoposide Work?
Etoposide works by inhibiting an enzyme called topoisomerase II, which cancer cells need to manage and repair their DNA during cell division.
By interfering with this enzyme, etoposide causes breaks in the cancer cells' DNA and prevents them from multiplying normally. This can lead to cancer cell death.
The therapeutic response develops over the course of treatment and is assessed by the oncology team using clinical evaluations and appropriate investigations.
How to Take Etoposide
Take Etoposide exactly as prescribed by your healthcare professional.
Etoposide 100mg/5ml Injection is administered by slow intravenous infusion into a vein.
The concentrate must be diluted appropriately before administration. It must not be injected undiluted or given as a rapid intravenous injection.
The infusion is generally administered over 30–60 minutes, although the duration may vary according to the treatment protocol and clinical circumstances.
Treatment is usually given in cycles, with the schedule determined by the oncologist.
Blood counts and kidney and liver function may need regular monitoring during treatment.
Do not stop, delay or change your chemotherapy schedule without consulting your oncology team.
This medicine must be prepared and administered by qualified healthcare professionals experienced in cancer chemotherapy.
Important Safety Information
Before starting treatment, tell your doctor or pharmacist about your medical history and all medicines, supplements and herbal products you use.
Etoposide requires particular caution in patients with:
Low blood cell counts: Etoposide can suppress bone marrow activity, reducing white blood cells, red blood cells and platelets.
Liver problems: Impaired liver function may affect how the medicine is processed.
Kidney problems: Reduced kidney function may affect medicine clearance and require treatment adjustments.
Existing infections: Reduced white blood cell counts can increase the risk of serious infections.
Low blood albumin levels: These may increase the risk of certain etoposide-related toxicities.
Previous allergic reactions: Inform your doctor about any previous hypersensitivity to etoposide or its ingredients.
Important medicine interactions:
Etoposide may interact with:
Cyclosporine, particularly at high doses, which may increase etoposide exposure.
Other chemotherapy medicines, which may increase bone marrow suppression and other treatment-related toxicities.
Medicines that affect drug-metabolising enzymes, potentially altering etoposide exposure.
Your healthcare professional should review possible interactions and determine whether any treatment adjustments or additional monitoring are necessary.
Pregnancy & Breastfeeding
Pregnancy: Etoposide can cause harm to an unborn baby and is generally avoided during pregnancy. Women who are pregnant, planning to become pregnant or who may be pregnant should inform their oncologist before treatment. Effective contraception should be discussed during treatment and for the recommended period afterwards.
Breastfeeding: Breastfeeding is generally not recommended during etoposide treatment because of the potential risk of serious adverse effects in the nursing infant. The appropriate time to resume breastfeeding should be discussed with the treating oncologist.
Both men and women should discuss fertility preservation and contraception before starting treatment, as etoposide may affect reproductive function.
Side Effects
Like all medicines, Etoposide can cause side effects, although not everyone experiences them.
Common or recognised side effects include:
Nausea and vomiting
Hair loss (alopecia)
Reduced white blood cell counts
Reduced platelet counts
Anaemia (low red blood cell counts)
Loss of appetite
Diarrhoea
Mouth sores or inflammation (stomatitis)
Fatigue and weakness
Seek prompt medical attention if you experience fever, chills, signs of infection, unusual bleeding or bruising, difficulty breathing, facial or throat swelling, severe dizziness or a severe allergic reaction. These symptoms may indicate serious complications, including bone marrow suppression or an infusion-related reaction.
This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.
Storage
Store Etoposide according to the instructions shown on the original product packaging.
Keep the medicine in its original packaging until required for use.
Protect it from light where specified by the product manufacturer.
Follow the manufacturer's instructions regarding temperature and refrigeration. Storage requirements may differ between product presentations.
Keep out of reach of children.
Do not use the injection after its expiry date.
Diluted solutions must be stored and used within the time specified in the applicable product information.
Etoposide is a cytotoxic medicine and requires appropriate handling and disposal by trained healthcare professionals.